John Agwunobi

Track

Insider profile

Currently holds positions in Herbalife Nutrition Ltd and bluebird bio Inc

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Co-President and Chief Health and Nutrition Officer Herbalife Nutrition Ltd May 1, 2018 -
Independent Director bluebird bio Inc June 8, 2017 -
Independent Director Magellan Health Inc Dec. 11, 2014 - May 1, 2019
John Agwunobi's trades of Ensign Group Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
389.16
Quantity 74,808 -18.7%
Value US$4,343,121
Transaction date
Proposed sale
Price
155.22
Quantity 96,255
Value US$4,903,190
Transaction date
Planned sale
Price
337.32
Quantity 86,050 -1.7%
Value US$92,413
Transaction date
Proposed sale
Price
199.97
Quantity 392
Value US$78,388
Transaction date
Planned sale
Price
178.31
Quantity 146 -1.6%
Value US$26,033
Transaction date
Proposed sale
Price
178.31
Quantity 146
Value US$26,033
Transaction date
Planned sale
Price
179.82
Quantity 246 -2.6%
Value US$44,236
Transaction date
Proposed sale
Price
179.82
Quantity 246
Value US$44,236
Transaction date
Planned sale
Price
188.87
Quantity 246 -2.7%
Value US$46,462
Transaction date
Proposed sale
Price
188.87
Quantity 246
Value US$46,462
Transaction date
Purchase
Price
117.58
Quantity 0 +0.0%
Value US$18
Transaction date
Planned purchase
Price
23.55
Quantity 4,222 +3.2%
Value US$99,434
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-22 2026-07-20
PlS Planned sale
74,808 -18.7%
389.16
US$4,343,121 		74,808 -18.7% 389.16 US$4,343,121
2026-07-20 2026-07-20
PrS Proposed sale
96,255
155.22
US$4,903,190 		96,255 155.22 US$4,903,190
2026-04-22 2026-04-20
PlS Planned sale
86,050 -1.7%
337.32
US$92,413 		86,050 -1.7% 337.32 US$92,413
2026-04-20 2026-04-20
PrS Proposed sale
392
199.97
US$78,388 		392 199.97 US$78,388
2026-01-22 2026-01-21
PlS Planned sale
146 -1.6%
178.31
US$26,033 		146 -1.6% 178.31 US$26,033
2026-01-21 2026-01-21
PrS Proposed sale
146
178.31
US$26,033 		146 178.31 US$26,033
2026-01-22 2026-01-20
PlS Planned sale
246 -2.6%
179.82
US$44,236 		246 -2.6% 179.82 US$44,236
2026-01-20 2026-01-20
PrS Proposed sale
246
179.82
US$44,236 		246 179.82 US$44,236
2025-11-07 2025-11-06
PlS Planned sale
246 -2.7%
188.87
US$46,462 		246 -2.7% 188.87 US$46,462
2025-11-06 2025-11-06
PrS Proposed sale
246
188.87
US$46,462 		246 188.87 US$46,462
2024-05-02 2024-04-30
B Purchase
0 +0.0%
117.58
US$18 		0 +0.0% 117.58 US$18
2022-05-11 2022-05-10
PP Planned purchase
4,222 +3.2%
23.55
US$99,434 		4,222 +3.2% 23.55 US$99,434